Literature DB >> 30094521

Strain variation and antigenic divergence among Bordetella pertussis circulating strains isolated from patients in Iran.

Fatemah Sadeghpour Heravi1, Vajihe Sadat Nikbin1, Masomeh Nakhost Lotfi1, Pouran Badiri1, Nazanin Jannesar Ahmadi1, Seyed Mohsen Zahraei1, Fereshteh Shahcheraghi2.   

Abstract

Despite global efforts and widespread vaccination to control whooping cough (pertussis) caused by B. pertussis, the re-emergence of pertussis still is being reported all over the world. Antigenic divergence in B. pertussis virulence factors is one of the reasons of pertussis resurgence, resulting in dissimilarity of local and vaccine strains. In this study, clonal spread and variation of B. pertussis virulence factor in isolated strains from Iranian patients have been analyzed. A total of 100 B. pertussis isolates were obtained from Pertussis Reference Laboratory of Pasteur Institute of Iran. Real-time PCR were performed to confirm the B. pertussis strains. The genomic patterns of B. pertussis strains were analyzed by pulsed-field gel electrophoresis (PFGE). Predominant alleles of local strains were ptxP3, ptxA1, prn2, fim 2-1, fim3-2, and cya2. PFGE results showed 25 patterns clustered into 18 PFGE groups. A few similarities between the circulating isolates, vaccine, and standard strains were obtained. Significantly, 48% of the isolates showed dominant pattern with different allelic profiles from vaccine strains. According to the genomic profiles, the clonal spread was observed among the circulating strains. Predominant virulence factor profile was also comparable with other countries. It may be suggested that strain variation between vaccine and local strains may have an effect on pertussis resurgence in Iran like other parts of the world.

Entities:  

Keywords:  Bordetella pertussis; Pulsed-field gel electrophoresis (PFGE); Resurgence; Vaccine; Virulence factors

Mesh:

Substances:

Year:  2018        PMID: 30094521     DOI: 10.1007/s10096-018-3323-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  45 in total

1.  [Increase in the incidence of pertussis and quality of whole-cell pertussis component of the DTP vaccine produced in Poland. Part I. Potency of DTP vaccine].

Authors:  Anna Gzyl; Grzegorz Gniadek; Ewa Augustynowicz; Daniel Rabczenko; Barbara Husejnow; Monika Zawadka; Janusz Slusarczyk
Journal:  Przegl Epidemiol       Date:  2004

2.  Analysis of Bordetella pertussis populations in European countries with different vaccination policies.

Authors:  S C M van Amersfoorth; L M Schouls; H G J van der Heide; A Advani; H O Hallander; K Bondeson; C H W von König; M Riffelmann; C Vahrenholz; N Guiso; V Caro; E Njamkepo; Q He; J Mertsola; F R Mooi
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model.

Authors:  Eiji Komatsu; Fuminori Yamaguchi; Akio Abe; Alison A Weiss; Mineo Watanabe
Journal:  Clin Vaccine Immunol       Date:  2010-03-31

4.  The pertussis problem: classical epidemiology and strain characterization should go hand in hand.

Authors:  Frits R Mooi; Anne Zeddeman; Marjolein van Gent
Journal:  J Pediatr (Rio J)       Date:  2015-02-20       Impact factor: 2.197

5.  Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland.

Authors:  Alex-Mikael Barkoff; Jussi Mertsola; Sophie Guillot; Nicole Guiso; Guy Berbers; Qiushui He
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

6.  California pertussis epidemic, 2010.

Authors:  Kathleen Winter; Kathleen Harriman; Jennifer Zipprich; Robert Schechter; John Talarico; James Watt; Gilberto Chavez
Journal:  J Pediatr       Date:  2012-07-21       Impact factor: 4.406

7.  Surveillance of Circulating Bordetella pertussis Strains in Europe during 1998 to 2015.

Authors:  Alex-Mikael Barkoff; Jussi Mertsola; Denis Pierard; Tine Dalby; Silje Vermedal Hoegh; Sophie Guillot; Paola Stefanelli; Marjolein van Gent; Guy Berbers; Didrik F Vestrheim; Margrethe Greve-Isdahl; Lena Wehlin; Margaretha Ljungman; Norman K Fry; Kevin Markey; Kari Auranen; Qiushui He
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

8.  Studies on Prn variation in the mouse model and comparison with epidemiological data.

Authors:  Marjolein van Gent; Inge H M van Loo; Kees J Heuvelman; Albert J de Neeling; Peter Teunis; Frits R Mooi
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

9.  Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

Authors:  F R Mooi; I H van Loo; A J King
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

10.  Pertussis epidemic--California, 2014.

Authors:  Kathleen Winter; Carol Glaser; James Watt; Kathleen Harriman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-12-05       Impact factor: 17.586

View more
  5 in total

1.  Genome diversity and evolutionary characteristics of clinical isolates of Bordetella pertussis circulating in Iran.

Authors:  Samaneh Saedi; Azadeh Safarchi; Mojtaba Noofeli; Keyvan Tadayon; Alfred Chin Yen Tay; Binit Lamichhane; Hamzeh Rahimi; Fereshteh Shahcheraghi
Journal:  Iran J Microbiol       Date:  2020-02

2.  Immuno-proteomics analysis between OMV of vaccine and dominant wild type strains of Bordetella pertussis in Iran.

Authors:  Ali Badamchi; Fariborz Bahrami; Alireza Hadizadeh Tasbiti; Shamsi Yari; Morvarid Shafiei; Fereshteh Shahcheraghi; Seyed Davar Siadat
Journal:  Iran J Microbiol       Date:  2020-04

3.  Evaluation of Outer Membrane Vesicles Obtained from Predominant Local Isolate of Boredetella pertussis as a Vaccine Candidate.

Authors:  Maryam Sadat Soltani; Mojtaba Noofeli; Seyed Reza Banihashemi; Fereshteh Shahcheraghi; Fereshteh Eftekhar
Journal:  Iran Biomed J       Date:  2021-11-01

4.  Fha Deficient Bordetella pertussis Isolates in Iran with 50 Years Whole Cell Pertussis Vaccination.

Authors:  Samaneh Saedi; Azadeh Safarchi; Faranak Tayebzadeh Moghadam; Siamak Heidarzadeh; Vajihe Sadat Nikbin; Fereshteh Shahcheraghi
Journal:  Iran J Public Health       Date:  2021-07       Impact factor: 1.429

5.  Genomic epidemiology of Iranian Bordetella pertussis: 50 years after the implementation of whole cell vaccine.

Authors:  Azadeh Safarchi; Sophie Octavia; Vajihe Sadat Nikbin; Masoumeh Nakhost Lotfi; Seyed Mohsen Zahraei; Chin Yen Tay; Binit Lamichhane; Fereshteh Shahcheraghi; Ruiting Lan
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.